SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Doyle William R.

(Last)

(First)

(Middle)

2484 BRIARCLIFF RD NE, #22,

SUITE 159

(Street)

ATLANTA

30329

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Vystar Corp [ VYST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2014

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/17/2014		P		500,000	A	$0.05⁽¹⁾	2,290,183	D
Common Stock								64,000⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock Warrant (Right to Buy)	$0.09	10/16/2014		J⁽³⁾		81,380		10/16/2014	10/16/2024	Common Stock	81,380	⁽³⁾	81,380	D
Common Stock Warrant (Right to Buy)	$0.1	10/16/2014		J⁽⁴⁾		73,144		10/16/2014	10/16/2024	Common Stock	73,144	⁽⁴⁾	73,144	D
Director Stock Option (Right to Buy)	$0.11	10/17/2014		D⁽⁵⁾			500,000	⁽⁶⁾	07/09/2024	Common Stock	500,000	$0.00	0	D
Director Stock Option (Right to Buy)	$0.05	10/17/2014		A⁽⁵⁾		500,000		⁽⁶⁾	07/09/2024	Common Stock	500,000	$0.00	500,000	D
Common Stock Warrant (Right to Buy)	$0.06	10/17/2014		D⁽⁷⁾			182,197	01/31/2014	01/31/2024	Common Stock	182,197	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		182,197		01/31/2014	01/31/2024	Common Stock	182,197	$0.00	182,197	D
Common Stock Warrant (Right to Buy)	$0.12	10/17/2014		D⁽⁷⁾			81,398	03/28/2014	03/28/2024	Common Stock	81,398	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		81,398		03/28/2014	03/28/2024	Common Stock	81,398	$0.00	81,398	D
Common Stock Warrant (Right to Buy)	$0.15	10/17/2014		D⁽⁷⁾			66,442	04/25/2014	04/25/2024	Common Stock	66,442	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		66,442		04/25/2014	04/25/2024	Common Stock	66,442	$0.00	66,442	D
Common Stock Warrant (Right to Buy)	$0.12	10/17/2014		D⁽⁷⁾			60,713	05/23/2014	05/23/2024	Common Stock	60,713	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		60,713		05/23/2014	05/23/2024	Common Stock	60,713	$0.00	60,713	D
Common Stock Warrant (Right to Buy)	$0.15	10/17/2014		D⁽⁷⁾			52,011	06/30/2014	06/30/2024	Common Stock	52,011	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		52,011		06/30/2014	06/30/2024	Common Stock	52,011	$0.00	52,011	D
Common Stock Warrant (Right to Buy)	$0.09	10/17/2014		D⁽⁷⁾			28,540	⁽⁸⁾	09/13/2023	Common Stock	28,540	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		D⁽⁷⁾		28,540		⁽⁸⁾	09/13/2023	Common Stock	28,540	$0.00	28,540	D
Common Stock Warrant (Right to Buy)	$0.08	10/17/2014		D⁽⁷⁾			33,363	⁽⁸⁾	09/27/2023	Common Stock	33,363	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		33,363		⁽⁸⁾	09/27/2023	Common Stock	33,363	$0.00	33,363	D
Common Stock Warrant (Right to Buy)	$0.07	10/17/2014		D⁽⁷⁾			39,562	⁽⁸⁾	10/11/2023	Common Stock	39,562	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		39,562		⁽⁸⁾	10/11/2023	Common Stock	39,562	$0.00	39,562	D
Common Stock Warrant (Right to Buy)	$0.06	10/17/2014		D⁽⁷⁾			32,835	⁽⁸⁾	10/25/2023	Common Stock	32,835	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		32,835		⁽⁸⁾	10/25/2023	Common Stock	32,835	$0.00	32,835	D
Common Stock Warrant (Right to Buy)	$0.1	10/17/2014		D⁽⁷⁾			44,859	⁽⁸⁾	12/02/2021	Common Stock	44,859	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		44,859		⁽⁸⁾	12/02/2021	Common Stock	44,859	$0.00	44,859	D
Common Stock Warrant (Right to Buy)	$0.1	10/17/2014		D⁽⁷⁾			67,576	⁽⁸⁾	12/30/2021	Common Stock	67,576	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		67,576		⁽⁸⁾	12/30/2021	Common Stock	67,576	$0.00	67,576	D
Common Stock Warrant (Right to Buy)	$0.1	10/17/2014		D⁽⁷⁾			68,768	⁽⁸⁾	01/26/2022	Common Stock	68,768	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		68,768		⁽⁸⁾	01/26/2022	Common Stock	68,768	$0.00	68,768	D
Common Stock Warrant (Right to Buy)	$0.1	10/17/2014		D⁽⁷⁾			69,770	⁽⁸⁾	02/23/2022	Common Stock	69,770	$0.00	0	D
Common Stock Warrant (Right to Buy)	$0.05	10/17/2014		A⁽⁷⁾		69,770		⁽⁸⁾	02/23/2022	Common Stock	69,770	$0.00	69,770	D

Explanation of Responses:

1. The shares were purchased by Mr. Doyle in exchange for his foregoing reimbursement of deferred compensation in the amount of $25,000.

2. Held by Royal Bank of Canada Custodian FBO William R. Doyle RLVR IRA.

3. The securities were issued to Mr. Doyle in exchange for his foregoing reimbursement of deferred compensation in the amount of $7,115.38.

4. The securities were issued to Mr. Doyle in exchange for his foregoing reimbursement of deferred compensation in the amount of $7,115.38.

5. The reported transaction involved an amendment of the exercise price of an outstanding stock option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option.

6. The option is exercisable in equal installments of 25,000 shares at the end of each financial quarter (the "Vesting Date"), beginning on September 30, 2014 for a period of five (5) years, ending on June 30, 2019, provided that the continuous service of the Optionee as a member of the Company's Board of Directors continues through and on the applicable Vesting Date.

7. The reported transaction involved an amendment of the exercise price of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a replacement warrant.

8. The warrant is exercisable immediately.

Remarks:

Form 1 of 3.

	Gerald L. Baxter, Attorney-in-Fact	10/20/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.